We represented a provider of SaaS based services that enabled the web-based integration of disparate healthcare IT systems. We represented the client in connection with its technology law matters and technology transactions, including strategic alliances and development agreements, and advised the client regarding structuring its technology transactions. We represented the client in multiple private label and reseller transactions, established their entire licensing system for customer-facing agreements, and represented the client in a technology development, transfer and license-back transaction with a strategic partner, for data transfer components of its platform.
Representation of a SaaS Technology Provider in IP Transactions
You Also May Be Interested In:
Lead Counsel to POINT Biopharma Inc. in its SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder
We represented Tractor Supply Company (Nasdaq: TSCO) in their agreement to acquire Orscheln Farm and Home, a family-owned farm and ranch retailer.